Zolpidem
- Generic Name
- Zolpidem
- Brand Names
- Ambien, Edluar, Intermezzo, Tovalt
- Drug Type
- Small Molecule
- Chemical Formula
- C19H21N3O
- CAS Number
- 82626-48-0
- Unique Ingredient Identifier
- 7K383OQI23
- Background
Zolpidem, also known as Ambien, is a hypnotic drug that was initially approved by the FDA in 1992 . Zolpidem improves sleep in patients with insomnia. It is aimed for use in patients with difficulties initiating sleep. This drug decreases the time to fall asleep (sleep latency), increases the duration of sleep, and decreases the number of awakenings during s...
- Indication
This drug is indicated for the short-term treatment of insomnia in adults characterized by difficulties with sleep initiation .
- Associated Conditions
- Insomnia
- Associated Therapies
- -
A Study of FK199B to Compare Efficacy With Zolpidem by Polysomnography in Patients With Insomnia
- Conditions
- Interventions
- First Posted Date
- 2009-10-21
- Last Posted Date
- 2014-08-20
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 55
- Registration Number
- NCT00999219
Study to Investigate the Effects of Melatonin, Temazepam & Zolpidem on Sleep EEG in Men and Women
- Conditions
- Interventions
- First Posted Date
- 2009-07-16
- Last Posted Date
- 2011-08-08
- Lead Sponsor
- University of Surrey
- Target Recruit Count
- 16
- Registration Number
- NCT00940550
- Locations
- 🇬🇧
Surrey CRC, University of Surrey, Egerton Road, Guildford, Surrey, United Kingdom
Sleep and Endometrial Cancer
- Conditions
- Interventions
- First Posted Date
- 2009-07-10
- Last Posted Date
- 2014-04-24
- Lead Sponsor
- University of Pittsburgh
- Target Recruit Count
- 6
- Registration Number
- NCT00936598
- Locations
- 🇺🇸
Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania, United States
🇺🇸UPMC Mercy, Pittsburgh, Pennsylvania, United States
The Effect of Marijuana and Prescription Medications in Mood, Performance and Sleep
- Conditions
- Interventions
- First Posted Date
- 2009-05-05
- Last Posted Date
- 2013-12-05
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 36
- Registration Number
- NCT00893269
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia
- Conditions
- Interventions
- First Posted Date
- 2008-11-04
- Last Posted Date
- 2012-02-29
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 643
- Registration Number
- NCT00784875
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Lakewood, Washington, United States
Memory Consolidation in Pharmacologically Enhanced Naps
- First Posted Date
- 2008-10-22
- Last Posted Date
- 2021-07-28
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 30
- Registration Number
- NCT00777829
- Locations
- 🇺🇸
UCSD General Clinical Research Center Laboratory for Sleep and Chronobiology (GCRC-LSC), La Jolla, California, United States
Effect Of Treatment With Oral Zolpidem On Polysomnography And Actigraphy Measures In Healthy Volunteers
- First Posted Date
- 2008-07-16
- Last Posted Date
- 2009-04-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 11
- Registration Number
- NCT00716521
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States
Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in Women
- Conditions
- Interventions
- First Posted Date
- 2008-05-12
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 8
- Registration Number
- NCT00676026
- Locations
- 🇺🇸
Yale University School of Medicine; Yale Program for Women's Reproductive Behavioral Health, New Haven, Connecticut, United States
The Role of Partial Reinforcement in the Long Term Management of Insomnia
- First Posted Date
- 2008-04-21
- Last Posted Date
- 2017-08-07
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 129
- Registration Number
- NCT00662155
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Zolpidem (Myslee) Post Marketing Study in Adolescent Patients With Insomnia - Evaluation With Polysomnography
- Conditions
- Interventions
- First Posted Date
- 2008-04-07
- Last Posted Date
- 2017-02-17
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 11
- Registration Number
- NCT00653562
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.